|
GB806876A
(en)
|
1956-02-16 |
1959-01-07 |
Wellcome Found |
Improvements in and relating to disposable hypodermic injection devices
|
|
GB873526A
(en)
|
1957-08-14 |
1961-07-26 |
Upjohn Co |
Fluid compositions comprising (acetyl-salicylic acid)-anhydride
|
|
GB887872A
(en)
|
1958-06-25 |
1962-01-24 |
Upjohn Co |
Improvements in or relating to pharmaceutical preparations
|
|
DE1467938C3
(de)
|
1964-05-22 |
1973-12-20 |
F. Hoffmann-La Roche & Co Ag, Basel (Schweiz) |
Wasserdispergierbares Arzneipräparat für Tiere
|
|
JPS5078634A
(enExample)
|
1973-11-16 |
1975-06-26 |
|
|
|
IE52535B1
(en)
|
1981-02-16 |
1987-12-09 |
Ici Plc |
Continuous release pharmaceutical compositions
|
|
US4530840A
(en)
|
1982-07-29 |
1985-07-23 |
The Stolle Research And Development Corporation |
Injectable, long-acting microparticle formulation for the delivery of anti-inflammatory agents
|
|
US4906474A
(en)
|
1983-03-22 |
1990-03-06 |
Massachusetts Institute Of Technology |
Bioerodible polyanhydrides for controlled drug delivery
|
|
US4725442A
(en)
|
1983-06-17 |
1988-02-16 |
Haynes Duncan H |
Microdroplets of water-insoluble drugs and injectable formulations containing same
|
|
US4622219A
(en)
|
1983-06-17 |
1986-11-11 |
Haynes Duncan H |
Method of inducing local anesthesia using microdroplets of a general anesthetic
|
|
US4891225A
(en)
|
1984-05-21 |
1990-01-02 |
Massachusetts Institute Of Technology |
Bioerodible polyanhydrides for controlled drug delivery
|
|
US4588580B2
(en)
|
1984-07-23 |
1999-02-16 |
Alaz Corp |
Transdermal administration of fentanyl and device therefor
|
|
US4534974A
(en)
|
1984-07-31 |
1985-08-13 |
Carter-Wallace, Inc. |
Pharmaceutical compositions with codeine
|
|
US4626539A
(en)
|
1984-08-10 |
1986-12-02 |
E. I. Dupont De Nemours And Company |
Trandermal delivery of opioids
|
|
US4573995A
(en)
|
1984-10-09 |
1986-03-04 |
Alza Corporation |
Transdermal therapeutic systems for the administration of naloxone, naltrexone and nalbuphine
|
|
US4804663A
(en)
|
1985-03-27 |
1989-02-14 |
Janssen Pharmaceutica N.V. |
3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles
|
|
GB8522453D0
(en)
|
1985-09-11 |
1985-10-16 |
Lilly Industries Ltd |
Chewable capsules
|
|
JPS62298530A
(ja)
|
1986-06-16 |
1987-12-25 |
Otsuka Pharmaceut Co Ltd |
坐薬用医薬組成物
|
|
IT1198449B
(it)
|
1986-10-13 |
1988-12-21 |
F I D I Farmaceutici Italiani |
Esteri di alcoli polivalenti di acido ialuronico
|
|
US4938763B1
(en)
|
1988-10-03 |
1995-07-04 |
Atrix Lab Inc |
Biodegradable in-situ forming implants and method of producing the same
|
|
US5702716A
(en)
|
1988-10-03 |
1997-12-30 |
Atrix Laboratories, Inc. |
Polymeric compositions useful as controlled release implants
|
|
US5008110A
(en)
|
1988-11-10 |
1991-04-16 |
The Procter & Gamble Company |
Storage-stable transdermal patch
|
|
CA2002299A1
(en)
|
1988-11-10 |
1990-05-10 |
Eugene G. Drust |
Compositions for the transdermal delivery of buprenorphine salts
|
|
US5026556A
(en)
|
1988-11-10 |
1991-06-25 |
Norwich Eaton Pharmaceuticals, Inc. |
Compositions for the transdermal delivery of pharmaceutical actives
|
|
US5487897A
(en)
|
1989-07-24 |
1996-01-30 |
Atrix Laboratories, Inc. |
Biodegradable implant precursor
|
|
US5324519A
(en)
|
1989-07-24 |
1994-06-28 |
Atrix Laboratories, Inc. |
Biodegradable polymer composition
|
|
DE3927113C2
(de)
|
1989-08-17 |
1993-11-25 |
Dolorgiet Gmbh & Co Kg |
Mittel zur Behandlung von schweren Schmerzzuständen und Verfahren zu ihrer Herstellung
|
|
US5096715A
(en)
|
1989-11-20 |
1992-03-17 |
Alko Ltd. |
Method and means for treating alcoholism by extinguishing the alcohol-drinking response using a transdermally administered opiate antagonist
|
|
US5558880A
(en)
|
1989-12-22 |
1996-09-24 |
Janssen Pharmaceutica Inc. |
Pharmaceutical and other dosage forms
|
|
US5660851A
(en)
|
1989-12-26 |
1997-08-26 |
Yissum Research Development Company Of The Hebrew Univ. Of Jerusalem |
Ocular inserts
|
|
ATE164080T1
(de)
|
1990-05-10 |
1998-04-15 |
Bechgaard Int Res |
Pharmazeutische zubereitung enthaltend n- glykofurole und n-äthylenglykole
|
|
US5069909A
(en)
|
1990-06-20 |
1991-12-03 |
Cygnus Therapeutic Systems |
Transdermal administration of buprenorphine
|
|
JPH0456736U
(enExample)
|
1990-09-14 |
1992-05-15 |
|
|
|
US5149543A
(en)
|
1990-10-05 |
1992-09-22 |
Massachusetts Institute Of Technology |
Ionically cross-linked polymeric microcapsules
|
|
WO1992014442A1
(en)
|
1991-02-18 |
1992-09-03 |
Commonwealth Scientific And Industrial Research Organisation |
Composition for use in transdermal administration
|
|
JP3145742B2
(ja)
|
1991-09-19 |
2001-03-12 |
日東電工株式会社 |
ゴム系感圧性接着剤とその接着シ―ト
|
|
AU2605592A
(en)
|
1991-10-15 |
1993-04-22 |
Atrix Laboratories, Inc. |
Polymeric compositions useful as controlled release implants
|
|
WO1993023019A1
(en)
|
1992-05-11 |
1993-11-25 |
Sri International |
Transdermal drug delivery systems and related compositions and methods of use
|
|
DK0669128T3
(da)
|
1992-11-17 |
2000-06-19 |
Yoshitomi Pharmaceutical |
Sustained-release mikrosfære indeholdende antipsykotikum og fremgangsmåde til at fremstille samme
|
|
TW376319B
(en)
|
1993-04-28 |
1999-12-11 |
Janssen Pharmaceutica Nv |
Pharmaceutical composition containing risperidone pamoate and having a long acting activity for treating psychoses induced by the release of dopamine
|
|
JP2651106B2
(ja)
|
1993-06-28 |
1997-09-10 |
大同鋼板株式会社 |
金属屋根材の葺設構造及びその葺設方法
|
|
NZ260909A
(en)
|
1993-07-05 |
1995-04-27 |
Takeda Chemical Industries Ltd |
Production of sustained release preparation by allowing a water-soluble polypeptide to permeate into a biodegradable matrix in an aqueous solution
|
|
US5643605A
(en)
|
1993-10-25 |
1997-07-01 |
Genentech, Inc. |
Methods and compositions for microencapsulation of adjuvants
|
|
JPH09505308A
(ja)
|
1993-11-19 |
1997-05-27 |
アルカーミズ・コントロールド・セラピューティクス・インコーポレイテッド・トゥー |
生物学的活性剤を含有する生分解性微粒子の製造
|
|
CN1074923C
(zh)
|
1993-11-19 |
2001-11-21 |
詹森药业有限公司 |
微囊密封的3-哌啶基取代的1,2-苯并异唑类和1,2-苯并异噻唑类
|
|
DE69534780T2
(de)
|
1994-04-08 |
2006-10-05 |
Qlt Usa Inc., Fort Collins |
Flüssige Zusammensetzungen zur Arzneistoffabgabe
|
|
US5453425A
(en)
|
1994-07-11 |
1995-09-26 |
Janssen Pharmaceutica N.V. |
Risperidone oral formulation
|
|
WO1996021427A1
(en)
|
1995-01-09 |
1996-07-18 |
Atrix Laboratories, Inc. |
Liquid polymer delivery system
|
|
JP3274579B2
(ja)
|
1995-01-12 |
2002-04-15 |
住友製薬株式会社 |
脳血管障害に伴う精神症候治療剤
|
|
US7833543B2
(en)
|
1995-06-07 |
2010-11-16 |
Durect Corporation |
High viscosity liquid controlled delivery system and medical or surgical device
|
|
US6413536B1
(en)
|
1995-06-07 |
2002-07-02 |
Southern Biosystems, Inc. |
High viscosity liquid controlled delivery system and medical or surgical device
|
|
US5968542A
(en)
|
1995-06-07 |
1999-10-19 |
Southern Biosystems, Inc. |
High viscosity liquid controlled delivery system as a device
|
|
US5747058A
(en)
|
1995-06-07 |
1998-05-05 |
Southern Biosystems, Inc. |
High viscosity liquid controlled delivery system
|
|
DK1006935T3
(da)
|
1995-06-07 |
2005-06-06 |
Durect Corp |
Styret afgivelsessystem med en væske med höj viskositet
|
|
US5736152A
(en)
|
1995-10-27 |
1998-04-07 |
Atrix Laboratories, Inc. |
Non-polymeric sustained release delivery system
|
|
US6004969A
(en)
|
1996-04-15 |
1999-12-21 |
National Science Council |
Transdermal delivery of buprenorphine preparations
|
|
ATE223206T1
(de)
|
1996-05-07 |
2002-09-15 |
Alkermes Inc |
Verfahren zur herstellung von mikropartikeln
|
|
US5792477A
(en)
|
1996-05-07 |
1998-08-11 |
Alkermes Controlled Therapeutics, Inc. Ii |
Preparation of extended shelf-life biodegradable, biocompatible microparticles containing a biologically active agent
|
|
JP4346696B2
(ja)
|
1996-05-28 |
2009-10-21 |
久光製薬株式会社 |
経皮治療用装置
|
|
EP0910345B1
(en)
|
1996-06-17 |
2002-02-13 |
Janssen Pharmaceutica N.V. |
Biconvex rapidly disintegrating dosage forms
|
|
WO1998027963A2
(en)
|
1996-12-20 |
1998-07-02 |
Alza Corporation |
Gel composition and methods
|
|
DE19701912C1
(de)
|
1997-01-10 |
1998-05-14 |
Jenapharm Gmbh |
Injizierbares Implantat
|
|
US5948787A
(en)
|
1997-02-28 |
1999-09-07 |
Alza Corporation |
Compositions containing opiate analgesics
|
|
IT1292396B1
(it)
|
1997-06-23 |
1999-02-08 |
Lisapharma Spa |
Cerotto dermico avente elevata resistenza meccanica,flessibilita' trasparenza e conducibilita' elettrica nel trattamento di affezioni
|
|
US6622036B1
(en)
|
2000-02-09 |
2003-09-16 |
Cns Response |
Method for classifying and treating physiologic brain imbalances using quantitative EEG
|
|
EP0936406B1
(en)
|
1998-02-10 |
2004-05-06 |
General Electric Company |
Burner with uniform fuel/air premixing for low emissions combustion
|
|
ES2359973T3
(es)
|
1998-03-19 |
2011-05-30 |
MERCK SHARP & DOHME CORP. |
Composiciones poliméricas líquidas para la liberación controlada de sustancias bioactivas.
|
|
US7208011B2
(en)
|
2001-08-20 |
2007-04-24 |
Conor Medsystems, Inc. |
Implantable medical device with drug filled holes
|
|
US6261583B1
(en)
*
|
1998-07-28 |
2001-07-17 |
Atrix Laboratories, Inc. |
Moldable solid delivery system
|
|
US6703047B2
(en)
|
2001-02-02 |
2004-03-09 |
Incept Llc |
Dehydrated hydrogel precursor-based, tissue adherent compositions and methods of use
|
|
US6565874B1
(en)
|
1998-10-28 |
2003-05-20 |
Atrix Laboratories |
Polymeric delivery formulations of leuprolide with improved efficacy
|
|
US6143314A
(en)
*
|
1998-10-28 |
2000-11-07 |
Atrix Laboratories, Inc. |
Controlled release liquid delivery compositions with low initial drug burst
|
|
US6194006B1
(en)
|
1998-12-30 |
2001-02-27 |
Alkermes Controlled Therapeutics Inc. Ii |
Preparation of microparticles having a selected release profile
|
|
US6355657B1
(en)
|
1998-12-30 |
2002-03-12 |
Atrix Laboratories, Inc. |
System for percutaneous delivery of opioid analgesics
|
|
US6294192B1
(en)
|
1999-02-26 |
2001-09-25 |
Lipocine, Inc. |
Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
|
|
US6383471B1
(en)
|
1999-04-06 |
2002-05-07 |
Lipocine, Inc. |
Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents
|
|
US6291013B1
(en)
|
1999-05-03 |
2001-09-18 |
Southern Biosystems, Inc. |
Emulsion-based processes for making microparticles
|
|
DE19923551A1
(de)
|
1999-05-21 |
2000-11-30 |
Lohmann Therapie Syst Lts |
Pharmazeutisches Präparat mit dem Wirkstoff Diamorphin und seine Verwendung in einem Verfahren zur Behandlung der Opiatsucht
|
|
US6461631B1
(en)
|
1999-11-16 |
2002-10-08 |
Atrix Laboratories, Inc. |
Biodegradable polymer composition
|
|
PT1248596E
(pt)
|
2000-01-11 |
2007-06-21 |
Bertex Pharma Gmbh |
Kit para implantações contendo uma fase de veículo e um solvente
|
|
KR100393478B1
(ko)
|
2000-03-29 |
2003-08-06 |
주식회사종근당 |
자가유화 매트릭스형 경점막·경피흡수제제
|
|
US6897308B1
(en)
|
2000-05-05 |
2005-05-24 |
Rgp Life Sciences Limited |
Process for the preparation of anti-psychotic 3-[2-[-4-(6-fluoro-1,2-benziosoxazol-3-yl)-1-piperidinyl] ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one
|
|
US6264987B1
(en)
|
2000-05-19 |
2001-07-24 |
Alkermes Controlled Therapeutics Inc. Ii |
Method for preparing microparticles having a selected polymer molecular weight
|
|
US6495164B1
(en)
|
2000-05-25 |
2002-12-17 |
Alkermes Controlled Therapeutics, Inc. I |
Preparation of injectable suspensions having improved injectability
|
|
WO2002000137A1
(en)
|
2000-06-28 |
2002-01-03 |
Shukla Atul J |
Biodegradable vehicles and delivery systems of biologically active substances
|
|
DE10035889A1
(de)
|
2000-07-24 |
2002-02-14 |
Lohmann Therapie Syst Lts |
Medizinischer Haftkleber mit einem Gehalt an Zucker-Estern
|
|
PT1783118E
(pt)
|
2000-08-14 |
2008-08-19 |
Teva Pharma |
Preparação de risperidona
|
|
DE10044545A1
(de)
|
2000-09-05 |
2002-04-04 |
Roland Bodmeier |
Retardpartikeldispersion
|
|
IT250575Y1
(it)
|
2000-10-10 |
2003-09-24 |
Gimatic Spa |
Sistema di guida registrabile per griffe di pinze azionate da unfluido
|
|
AU2002226000A1
(en)
|
2000-11-13 |
2002-05-21 |
Atrix Laboratories, Inc. |
Injectable sustained release delivery system with loperamide
|
|
WO2002067895A2
(en)
|
2000-11-16 |
2002-09-06 |
Durect Corporation |
Implant dosage form and use thereof for the delivery of a cholesterol lowering agent
|
|
DK1372729T3
(da)
|
2001-02-23 |
2009-06-22 |
Genentech Inc |
Nedbrydelige polymere til injektion
|
|
US20040018238A1
(en)
|
2001-02-26 |
2004-01-29 |
Shukla Atul J |
Biodegradable vehicles and delivery systems of biolgically active substances
|
|
US20030009145A1
(en)
|
2001-03-23 |
2003-01-09 |
Struijker-Boudier Harry A.J. |
Delivery of drugs from sustained release devices implanted in myocardial tissue or in the pericardial space
|
|
US6558702B2
(en)
*
|
2001-04-13 |
2003-05-06 |
Alkermes Controlled Therapeutics, Inc. |
Method of modifying the release profile of sustained release compositions
|
|
GB0112324D0
(en)
|
2001-05-21 |
2001-07-11 |
Croda Int Plc |
Compounds
|
|
US20030068375A1
(en)
|
2001-08-06 |
2003-04-10 |
Curtis Wright |
Pharmaceutical formulation containing gelling agent
|
|
JP2003063954A
(ja)
|
2001-08-24 |
2003-03-05 |
Saitama Daiichi Seiyaku Kk |
リザーバー型貼付剤
|
|
KR20040058100A
(ko)
|
2001-11-14 |
2004-07-03 |
알자 코포레이션 |
주입가능한 데포 조성물 및 그의 용도
|
|
WO2003041685A1
(en)
|
2001-11-14 |
2003-05-22 |
Alza Corporation |
Injectable depot composition
|
|
US7829109B2
(en)
|
2001-11-14 |
2010-11-09 |
Durect Corporation |
Catheter injectable depot compositions and uses thereof
|
|
US20040258731A1
(en)
|
2001-11-21 |
2004-12-23 |
Tsuyoshi Shimoboji |
Preparation approriate for cartilage tissue formation
|
|
JP2005528352A
(ja)
|
2002-03-12 |
2005-09-22 |
エチファルム |
生体活性物質の持続的放出に用いるためのゲル化特性を有する組成物
|
|
US7041320B1
(en)
|
2002-05-31 |
2006-05-09 |
Biotek, Inc. |
High drug loaded injectable microparticle compositions and methods of treating opioid drug dependence
|
|
MY139059A
(en)
|
2002-06-24 |
2009-08-28 |
Alza Corp |
Reusable, spring driven autoinjector
|
|
AR039729A1
(es)
|
2002-06-25 |
2005-03-09 |
Alza Corp |
Formulaciones de deposito de corta duracion
|
|
US20040003401A1
(en)
|
2002-06-27 |
2004-01-01 |
Koninklijke Philips Electronics N.V. |
Method and apparatus for using cluster compactness as a measure for generation of additional clusters for stereotyping programs
|
|
WO2004011065A1
(en)
|
2002-07-31 |
2004-02-05 |
Alza Corporation |
Injection device providing automatic needle retraction
|
|
AU2003256849A1
(en)
|
2002-07-31 |
2004-02-16 |
Alza Corporation |
Injectable multimodal polymer depot compositions and uses thereof
|
|
BR0306204A
(pt)
|
2002-08-30 |
2004-09-08 |
Torrent Pharmaceuticals Ltd |
Processo melhorado para a preparação de risperidona
|
|
JP2006501936A
(ja)
|
2002-10-04 |
2006-01-19 |
エラン ファーマ インターナショナル，リミティド |
固体ナノ粒子活性薬剤のガンマ線照射
|
|
US20120225033A1
(en)
|
2010-11-24 |
2012-09-06 |
Durect Corporation |
Biodegradable Drug Delivery Composition
|
|
KR20040034996A
(ko)
|
2002-10-18 |
2004-04-29 |
한미약품 주식회사 |
리스페리돈의 개선된 제조방법
|
|
DE10250084A1
(de)
|
2002-10-25 |
2004-05-06 |
Grünenthal GmbH |
Gegen Missbrauch gesicherte Darreichungsform
|
|
MXPA05002561A
(es)
|
2002-10-25 |
2005-05-05 |
Pfizer Prod Inc |
Nuevas formulaciones de liberacion prolongada inyectables.
|
|
US7368126B2
(en)
|
2002-11-06 |
2008-05-06 |
Guohua Chen |
Controlled release depot formulations
|
|
HUE026034T2
(en)
|
2002-12-13 |
2016-05-30 |
Durect Corp |
Oral delivery system containing an oral high-viscosity carrier
|
|
EP1596824A4
(en)
|
2003-02-04 |
2011-11-23 |
Chrysalis Tech Inc |
AEROSOL FORMULATIONS AND AEROSOL DISTRIBUTION OF BUSPIRONE, BUPRENORPHINE, TRIAZOLAM, CYCLOBENZAPRINE AND ZOLPIDEM
|
|
EP1610767B1
(en)
|
2003-03-26 |
2011-01-19 |
Egalet A/S |
Morphine controlled release system
|
|
EP1615924A1
(en)
|
2003-04-22 |
2006-01-18 |
Synthon B.V. |
Water soluble salts of risperidone
|
|
KR20060023140A
(ko)
|
2003-05-30 |
2006-03-13 |
알자 코포레이션 |
이식성 탄성중합체 데포 조성물, 이의 용도 및 이의제조방법
|
|
SI1635875T1
(sl)
|
2003-06-26 |
2009-04-30 |
Psivida Inc |
Sistem za dajanje zdravila, ki se gelira in situ
|
|
TWI357815B
(en)
|
2003-06-27 |
2012-02-11 |
Euro Celtique Sa |
Multiparticulates
|
|
FI20045223A7
(fi)
|
2004-06-15 |
2005-12-16 |
Bioretec Oy |
Monitoiminen biohajoava komposiitti ja kirurginen implantti, joka käsittää mainitun komposiitin
|
|
US20050032781A1
(en)
*
|
2003-08-06 |
2005-02-10 |
Elliot Ehrich |
Methods for administering active agents to CYP 2D6 sensitive patients
|
|
DE10336400A1
(de)
|
2003-08-06 |
2005-03-24 |
Grünenthal GmbH |
Gegen Missbrauch gesicherte Darreichungsform
|
|
US20070108405A1
(en)
|
2003-09-01 |
2007-05-17 |
Fh Faulding & Co., Ltd. |
Compositions and methods for delivery of biologically active agents
|
|
WO2005037949A2
(en)
|
2003-10-07 |
2005-04-28 |
Chrysalis Technologies Incorporated |
Aerosol formulations of butalbital, lorazepam, ipratropium, baclofen, morphine and scopolamine
|
|
US20070191815A1
(en)
|
2004-09-13 |
2007-08-16 |
Chrono Therapeutics, Inc. |
Biosynchronous transdermal drug delivery
|
|
US20050281879A1
(en)
|
2003-11-14 |
2005-12-22 |
Guohua Chen |
Excipients in drug delivery vehicles
|
|
US20050106214A1
(en)
|
2003-11-14 |
2005-05-19 |
Guohua Chen |
Excipients in drug delivery vehicles
|
|
US7201920B2
(en)
|
2003-11-26 |
2007-04-10 |
Acura Pharmaceuticals, Inc. |
Methods and compositions for deterring abuse of opioid containing dosage forms
|
|
JP4610567B2
(ja)
|
2003-12-05 |
2011-01-12 |
ゾゲニクス インコーポレーティッド |
無針注射器の送達準備器具
|
|
EP1711159B1
(en)
|
2003-12-30 |
2013-03-20 |
Durect Corporation |
Solid implants containing a block copolymer for controlled release of a gnrh compound
|
|
US8329203B2
(en)
|
2004-01-12 |
2012-12-11 |
The Trustees Of The University Of Pennsylvania |
Drug-containing implants and methods of use thereof
|
|
WO2005070332A1
(en)
|
2004-01-12 |
2005-08-04 |
The Trustees Of The University Of Pennsylvania |
Long-term delivery formulations and methods of use thereof
|
|
AU2006269927B2
(en)
|
2004-01-12 |
2013-05-16 |
The Trustees Of The University Of Pennsylvania |
Drug-containing implants and methods of use thereof
|
|
US8221778B2
(en)
|
2005-01-12 |
2012-07-17 |
The Trustees Of The University Of Pennsylvania |
Drug-containing implants and methods of use thereof
|
|
WO2005089670A1
(en)
|
2004-03-15 |
2005-09-29 |
Durect Corporation |
Pharmaceutical compositions for administration to a sinus
|
|
IS7290A
(is)
|
2004-05-28 |
2005-11-29 |
Actavis Group |
Lyfjasamsetningar sem innihalda risperidone
|
|
PL1768650T3
(pl)
|
2004-06-04 |
2009-01-30 |
Camurus Ab |
Ciekłe formulacje depot
|
|
EP1604693A1
(en)
|
2004-06-09 |
2005-12-14 |
Scil Technology GmbH |
In situ forming scaffold, its manufacturing and use
|
|
GB2418854B
(en)
|
2004-08-31 |
2009-12-23 |
Euro Celtique Sa |
Multiparticulates
|
|
JP2008520547A
(ja)
|
2004-10-04 |
2008-06-19 |
キューエルティー ユーエスエー，インコーポレイテッド． |
眼部送達のためのポリマー送達処方
|
|
US8313763B2
(en)
|
2004-10-04 |
2012-11-20 |
Tolmar Therapeutics, Inc. |
Sustained delivery formulations of rapamycin compounds
|
|
CN101146523B
(zh)
|
2004-10-21 |
2010-12-29 |
杜雷科特公司 |
透皮给药系统
|
|
AU2005304435B8
(en)
|
2004-11-10 |
2011-06-23 |
Tolmar Therapeutics, Inc. |
A stabilized polymeric delivery system
|
|
GB2420976B
(en)
|
2004-11-19 |
2006-12-20 |
Zvi Finkelstein |
Therapeutic implant
|
|
TWI369218B
(en)
|
2004-12-14 |
2012-08-01 |
Novartis Ag |
In situ forming implant for animals
|
|
CA2590696A1
(en)
|
2004-12-15 |
2006-06-22 |
Qlt Usa, Inc. |
Sustained delivery formulations of octreotide compounds
|
|
EP1830900A1
(en)
|
2004-12-16 |
2007-09-12 |
Miv Therapeutics Inc. |
Multi-layer drug delivery device and method of manufacturing same
|
|
US9415034B2
(en)
|
2005-01-05 |
2016-08-16 |
National Defense Medical Center |
Inhibitors and enhancers of uridine diphosphate-glucuronosyltransferase 2B (UGT2B)
|
|
EP1893159B1
(en)
|
2005-06-17 |
2015-09-30 |
Vital Health Sciences Pty Ltd. |
A carrier comprising one or more di- and/or monophosphate derivatives of electron transfer agents
|
|
US20070020186A1
(en)
|
2005-07-22 |
2007-01-25 |
Alpex Pharma S.A. |
Solid dosage formulations of narcotic drugs having improved buccal adsorption
|
|
EP1912627B1
(en)
|
2005-08-11 |
2016-08-10 |
Promedon S.A. |
Composition comprising polymeric, water-insoluble, anionic particles, processes and uses
|
|
US8852638B2
(en)
|
2005-09-30 |
2014-10-07 |
Durect Corporation |
Sustained release small molecule drug formulation
|
|
CA2627292C
(en)
|
2005-10-26 |
2012-04-17 |
Banner Pharmacaps, Inc. |
Hydrophilic vehicle-based dual controlled release matrix system
|
|
WO2007084460A2
(en)
|
2006-01-18 |
2007-07-26 |
Qps, Llc |
Pharmaceutical compositions with enhanced stability
|
|
US20090022798A1
(en)
|
2007-07-20 |
2009-01-22 |
Abbott Gmbh & Co. Kg |
Formulations of nonopioid and confined opioid analgesics
|
|
US8765178B2
(en)
|
2006-07-19 |
2014-07-01 |
Watson Laboratories, Inc. |
Controlled release formulations and associated methods
|
|
BRPI0716829A2
(pt)
|
2006-09-25 |
2013-10-29 |
Koninkl Philips Electronics Nv |
Dispositivo para executar um processo e para indicar ter atingido um estágio especificado do processo
|
|
CA2664986C
(en)
|
2006-10-02 |
2015-09-22 |
Labtec Gesellschaft Fuer Technologische Forschung Und Entwicklung Mbh |
Non-mucoadhesive film dosage forms
|
|
EA200970348A1
(ru)
|
2006-10-05 |
2009-10-30 |
Панацея Биотек Лтд. |
Новые инъецируемые депо-композиции и способ получения таких композиций
|
|
PT2079767E
(pt)
|
2006-10-11 |
2014-10-07 |
Tolmar Therapeutics Inc |
Preparação de poliésteres biodegradáveis com propriedades de baixa rotura por extração com fluido supercrítico
|
|
US8076448B2
(en)
|
2006-10-11 |
2011-12-13 |
Tolmar Therapeutics, Inc. |
Preparation of biodegradable polyesters with low-burst properties by supercritical fluid extraction
|
|
GB0620661D0
(en)
|
2006-10-18 |
2006-11-29 |
Pharmasol Ltd |
Novel compounds
|
|
HUE025842T2
(en)
|
2007-02-15 |
2016-04-28 |
Tolmar Therapeutics Inc |
Poly (lactide / glycolide) with reduced fracture properties and methods for producing polymers
|
|
CA2679316C
(en)
|
2007-03-02 |
2016-11-29 |
Teika Pharmaceutical Co., Ltd. |
Morphine composition for transdermal absorption, morphine composition storing unit and transdermal absorption preparation using the same
|
|
CA2682848A1
(en)
|
2007-04-03 |
2008-10-16 |
Trimeris, Inc. |
Novel formulations for delivery of antiviral peptide therapeutics
|
|
WO2008143992A2
(en)
|
2007-05-18 |
2008-11-27 |
Durect Corporation |
Improved depot formulations
|
|
MX354603B
(es)
|
2007-05-25 |
2018-03-13 |
Indivior Uk Ltd |
Formulaciones de transferencia sostenida de compuestos de risperidona.
|
|
CA2699172C
(en)
|
2007-09-03 |
2016-05-17 |
Nanotherapeutics, Inc |
Compositions and methods for delivery of poorly soluble drugs
|
|
EP2200588B1
(en)
|
2007-09-25 |
2019-03-20 |
Solubest Ltd. |
Compositions comprising lipophilic active compounds and method for their preparation
|
|
JP2011506318A
(ja)
|
2007-12-06 |
2011-03-03 |
デュレクト コーポレーション |
経口医薬製剤
|
|
FR2926996B1
(fr)
|
2008-01-31 |
2013-06-21 |
Ethypharm Sa |
Composition pharmaceutique a proprietes gelifiantes contenant un derive de tyrosine
|
|
EP2244679A4
(en)
|
2008-02-08 |
2013-10-09 |
Qps Llc |
NON-POLYMERIC COMPOSITIONS FOR CONTROLLED MEDICINAL PRODUCTION
|
|
CA2714506C
(en)
|
2008-02-08 |
2016-06-07 |
Qps Llc |
Composition for sustained release delivery of proteins or peptides
|
|
JP5286850B2
(ja)
|
2008-03-14 |
2013-09-11 |
大日本印刷株式会社 |
液体用紙容器用包装材料およびその包装材料から製造される液体用紙容器
|
|
WO2009120889A2
(en)
|
2008-03-26 |
2009-10-01 |
Alltranz Inc. |
Abuse deterrent transdermal formulations of opiate agonists and agonist-antagonists
|
|
DK2291174T3
(en)
|
2008-06-03 |
2015-03-09 |
Tolmar Therapeutics Inc |
Liquid compositions comprising biocompatible oligomer-polymer compositions
|
|
US8877225B2
(en)
|
2008-06-03 |
2014-11-04 |
Tolmar Therapeutics, Inc. |
Controlled release copolymer formulation with improved release kinetics
|
|
US8257722B2
(en)
|
2008-09-15 |
2012-09-04 |
Cv Ingenuity Corp. |
Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens
|
|
US8114429B2
(en)
|
2008-09-15 |
2012-02-14 |
Cv Ingenuity Corp. |
Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens
|
|
US8128951B2
(en)
|
2008-09-15 |
2012-03-06 |
Cv Ingenuity Corp. |
Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens
|
|
JP2012524771A
(ja)
|
2009-04-23 |
2012-10-18 |
ロンドンファーマ リミテッド |
中性油を含む舌下用の医薬組成物
|
|
CA2760615A1
(en)
|
2009-05-01 |
2010-11-04 |
Aptalis Pharmatech, Inc. |
Orally disintegrating tablet compositions comprising combinations of non-opioid and opioid analgesics
|
|
EP2445487A2
(en)
|
2009-06-24 |
2012-05-02 |
Egalet Ltd. |
Controlled release formulations
|
|
FR2949061B1
(fr)
|
2009-08-12 |
2013-04-19 |
Debregeas Et Associes Pharma |
Microgranules flottants
|
|
CA3063465C
(en)
|
2009-11-18 |
2023-01-03 |
Nektar Therapeutics |
Acid salt forms of polymer-drug conjugates and alkoxylation methods
|
|
WO2011088140A1
(en)
|
2010-01-12 |
2011-07-21 |
Nektar Therapeutics |
Pegylated opioids with low potential for abuse and side effects
|
|
CA2792866C
(en)
|
2010-03-15 |
2016-05-31 |
Ipsen Pharma S.A.S. |
Pharmaceutical compositions of growth hormone secretagogue receptor ligands
|
|
US20110230816A1
(en)
|
2010-03-18 |
2011-09-22 |
Tyco Healthcare Group Lp |
Gels for Transdermal Delivery
|
|
SMT202100679T1
(it)
|
2010-05-31 |
2022-01-10 |
Laboratorios Farmaceuticos Rovi S A |
Composizioni per impianti biodegradabili in-situ iniettabili
|
|
PT2394664T
(pt)
|
2010-05-31 |
2016-09-06 |
Farm Rovi Lab Sa |
Composição depot para injetável antipsicótico
|
|
WO2011161531A1
(en)
|
2010-06-24 |
2011-12-29 |
Torrent Pharmaceuticals Limited |
Pharmaceutical composition containing goserelin for in-situ implant
|
|
UY33618A
(es)
|
2010-09-21 |
2012-03-30 |
Purdue Pharma Lp |
Analogos de buprenorfina
|
|
CN103200944B
(zh)
|
2010-11-17 |
2016-05-04 |
赫克萨尔股份公司 |
包含丁丙诺啡的经皮治疗系统
|
|
AP2013006939A0
(en)
|
2010-11-26 |
2013-06-30 |
Univ Witwatersrand Jhb |
A drug delivery device
|
|
RS62059B1
(sr)
|
2011-05-31 |
2021-07-30 |
Laboratorios Farmaceuticos Rovi S A |
Kompozicija implanta risperidona i/ili paliperidona
|
|
TW201338813A
(zh)
|
2011-12-12 |
2013-10-01 |
Lohmann Therapie Syst Lts |
經皮遞送系統
|
|
US9468599B2
(en)
|
2011-12-27 |
2016-10-18 |
Cmpd Licensing, Llc |
Composition and method for compounded therapy
|
|
US20140134261A1
(en)
|
2012-08-21 |
2014-05-15 |
Trinity Laboratories, Inc. |
Pharmaceutical Compositions Comprising Capsaicin Esters for Treating Pain and Cold Sores
|
|
RU2513514C1
(ru)
|
2012-11-23 |
2014-04-20 |
Общество с ограниченной ответственностью "НПК "Трифарма" |
Фармацевтическая композиция, содержащая налбуфина гидрохлорид, ее применение для лечения болевого синдрома средней и высокой интенсивности и способ получения фармацевтической композиции
|
|
CN103142458B
(zh)
|
2013-01-22 |
2015-09-09 |
莱普德制药有限公司 |
无成瘾性镇痛缓释递药系统的组方与制备方法
|
|
US20140308352A1
(en)
|
2013-03-11 |
2014-10-16 |
Zogenix Inc. |
Compositions and methods involving polymer, solvent, and high viscosity liquid carrier material
|
|
CN115804749A
(zh)
|
2013-03-11 |
2023-03-17 |
度瑞公司 |
包含高粘度液体载体的可注射控制释放组合物
|
|
US9393211B2
(en)
|
2013-03-15 |
2016-07-19 |
Oakwood Laboratories LLC |
High drug load buprenorphine microspheres and method of producing same
|
|
WO2015092811A2
(en)
|
2013-11-21 |
2015-06-25 |
Yadav Akanksha Bindeshwari Prasad |
Oral films
|
|
US10525171B2
(en)
|
2014-01-24 |
2020-01-07 |
The Spectranetics Corporation |
Coatings for medical devices
|